Rejected post-Arthrex bids signal uncertainty over USPTO director’s authority

05-08-2021

Muireann Bolger

Rejected post-Arthrex bids signal uncertainty over USPTO director’s authority

Mark Van Scyoc / Shutterstock.com

Early signs show that US v Arthrex is unlikely to herald a spate of inter partes reviews, but may fuel uncertainty around the scope of the acting USPTO director’s role, lawyers have told WIPR.


Arthrex, SCOTUS, Drew Hirshfeld, USPTO, patents

WIPR